MARK2 and neoplasm: Consistent with previous findings, the low-risk group possessed a highly active immune status, including cytokine production, immune receptor activation, and the phosphatidyl-inositol 3-kinase/serine-threonine kinase (PI3K-Akt) signaling pathway, all of which corresponded to a hot tumor phenotype.